216 related articles for article (PubMed ID: 11778984)
1. Categorizing genetic tests to identify their ethical, legal, and social implications.
Burke W; Pinsky LE; Press NA
Am J Med Genet; 2001; 106(3):233-40. PubMed ID: 11778984
[TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
3. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
Schwartz MD; Lerman C; Brogan B; Peshkin BN; Isaacs C; DeMarco T; Halbert CH; Pennanen M; Finch C
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1003-7. PubMed ID: 15824179
[TBL] [Abstract][Full Text] [Related]
4. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation.
Stolier AJ; Fuhrman GM; Mauterer L; Bolton JS; Superneau DW
Breast J; 2004; 10(6):475-80. PubMed ID: 15569201
[TBL] [Abstract][Full Text] [Related]
5. The implications of genetic testing for deafness.
Arnos KS
Ear Hear; 2003 Aug; 24(4):324-31. PubMed ID: 12923423
[TBL] [Abstract][Full Text] [Related]
6. Attitudes regarding predictive genetic testing in minors: a survey of European clinical geneticists.
Borry P; Goffin T; Nys H; Dierickx K
Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):78-83. PubMed ID: 18200522
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
Chompret A
J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
[TBL] [Abstract][Full Text] [Related]
8. [BRCA1 and BRCA2 have reached the clinical medicine. The 10-year old finding of the genetic mutation makes it now possible to prevent breast cancer].
Loman N
Lakartidningen; 2004 Jun; 101(25):2172-7. PubMed ID: 15281304
[TBL] [Abstract][Full Text] [Related]
9. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
Forman AD; Hall MJ
Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
[TBL] [Abstract][Full Text] [Related]
10. Direct-to-patient BRCA1 testing: the Twoj Styl experience.
Gronwald J; Huzarski T; Byrski T; Debniak T; Metcalfe K; Narod SA; Lubiński J
Breast Cancer Res Treat; 2006 Dec; 100(3):239-45. PubMed ID: 16807675
[TBL] [Abstract][Full Text] [Related]
11. Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population.
Peterson EA; Milliron KJ; Lewis KE; Goold SD; Merajver SD
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):79-87. PubMed ID: 11815404
[TBL] [Abstract][Full Text] [Related]
12. [Prenatal diagnosis for hereditary predisposition to mammary and ovarian carcinoma--defining a position].
Cobben JM; Bröcker-Vriends AH; Leschot NJ
Ned Tijdschr Geneeskd; 2002 Aug; 146(31):1461-5. PubMed ID: 12190015
[TBL] [Abstract][Full Text] [Related]
13. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
14. Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients.
Vadaparampil ST; Quinn GP; Miree CA; Brzosowicz J; Carter B; Laronga C
Ann Surg Oncol; 2009 Jul; 16(7):1973-81. PubMed ID: 19408048
[TBL] [Abstract][Full Text] [Related]
15. Should genetic testing for BRCA1/2 be permitted for minors? Opinions of BRCA mutation carriers and their adult offspring.
Bradbury AR; Patrick-Miller L; Pawlowski K; Ibe CN; Cummings SA; Olopade OI; Daugherty CK
Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):70-7. PubMed ID: 18200524
[TBL] [Abstract][Full Text] [Related]
16. Bioethics for clinicians: 14. Ethics and genetics in medicine.
Burgess MM; Laberge CM; Knoppers BM
CMAJ; 1998 May; 158(10):1309-13. PubMed ID: 9614824
[TBL] [Abstract][Full Text] [Related]
17. Unambiguous test results or individual independence? The role of clients and families in predictive BRCA-testing in the Netherlands compared to the USA.
Boenink M
Soc Sci Med; 2011 Jun; 72(11):1793-801. PubMed ID: 20650557
[TBL] [Abstract][Full Text] [Related]
18. 'Indirect' BRCA1/2 testing: a useful approach in hereditary breast and ovarian cancer families without a living affected relative.
Cruger DG; Kruse TA; Gerdes AM
Clin Genet; 2005 Sep; 68(3):228-33. PubMed ID: 16098011
[TBL] [Abstract][Full Text] [Related]
19. Genetic health care services, present and near future in Japan.
Matsuda I
Eubios J Asian Int Bioeth; 2003 Mar; 13(2):57-9. PubMed ID: 17117541
[TBL] [Abstract][Full Text] [Related]
20. Ethical, social and legal implications of genetic testing in liver disease.
van Leeuwen DJ; Bernat JL
Hepatology; 2006 Jun; 43(6):1195-201. PubMed ID: 16729331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
